Vaxart's total assets for Q3 2025 were $208.99M, a decrease of ― from the previous quarter. VXRT total liabilities were $182.23M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.